Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock.

PubWeight™: 1.82‹?› | Rank: Top 3%

🔗 View Article (PMID 8857433)

Published in Intensive Care Med on January 01, 1996

Authors

G Bernardin1, C Pradier, F Tiger, P Deloffre, M Mattei

Author Affiliations

1: Service de Reanimation Medicale, Hopital l'Archet, Nice, France.

Articles citing this

Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation (2011) 1.87

Causes of death and determinants of outcome in critically ill patients. Crit Care (2006) 1.40

Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ (2005) 1.36

Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Crit Care (2009) 1.31

Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 hours in Intensive Care Unit: an observational study. Ann Intensive Care (2013) 1.15

Better lactate clearance associated with good neurologic outcome in survivors who treated with therapeutic hypothermia after out-of-hospital cardiac arrest. Crit Care (2013) 1.02

The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care (2016) 0.95

In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia. Br J Pharmacol (2002) 0.93

Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: the role of noninvasive ventilation. PLoS One (2012) 0.89

Equipment review: the success of early goal-directed therapy for septic shock prompts evaluation of current approaches for monitoring the adequacy of resuscitation. Crit Care (2005) 0.88

Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian J Crit Care Med (2011) 0.88

Point of care serum lactate levels as a prognostic marker of outcome in complex pediatric cardiac surgery patients: Can we utilize it? Indian J Crit Care Med (2012) 0.87

Lactic acidosis secondary to metformin overdose: a case report. J Med Case Rep (2012) 0.79

Two-hour lactate clearance predicts negative outcome in patients with cardiorespiratory insufficiency. Crit Care Res Pract (2010) 0.79

Resolution and outcome of acute circulatory failure does not correlate with hemodynamics. Crit Care (2003) 0.79

Effects of cardiopulmonary bypass on tight junction protein expressions in intestinal mucosa of rats. World J Gastroenterol (2008) 0.78

The riddle of hyperlactatemia. Crit Care (2009) 0.77

Serum arterial lactate concentration predicts mortality and organ dysfunction following liver resection. Perioper Med (Lond) (2013) 0.77

End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or...? Intensive Care Med (1996) 0.76

Blood lactate concentration as diagnostic predictors of uterine necrosis and its outcome in dairy cows with uterine torsion. J Vet Med Sci (2017) 0.75

Monitoring of serum lactate level during cardiopulmonary resuscitation in adult in-hospital cardiac arrest. Crit Care (2015) 0.75

Predictors of Acute Hemodynamic Decompensation in Early Sepsis: An Observational Study. J Clin Med Res (2016) 0.75

Basic arterial blood gas biomarkers as a predictor of mortality in tetralogy of Fallot patients. Ann Card Anaesth (2017) 0.75

Vasopressor therapy: not like antibiotics! Intensive Care Med (2016) 0.75

Clinical examination, critical care ultrasonography and outcomes in the critically ill: cohort profile of the Simple Intensive Care Studies-I. BMJ Open (2017) 0.75

Articles by these authors

Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS (2000) 2.14

AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13

Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98

Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994. Br J Obstet Gynaecol (1998) 1.68

An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res (1993) 1.60

Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res (1996) 1.48

Influence of alveolar ventilation changes on calculated gastric intramucosal pH and gastric-arterial PCO2 difference. Intensive Care Med (1999) 1.46

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med (2011) 1.43

[Prognosis of acute tuberculous respiratory distress syndrome. 4 cases]. Presse Med (1995) 1.39

Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat (2007) 1.39

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone (1996) 1.38

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV Med (2013) 1.28

HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania. Clin Infect Dis (2000) 1.28

Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups. N Engl J Med (2001) 1.27

Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23

Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer (1999) 1.20

The 30-kilodalton protein present in purified fusicoccin receptor preparations is a 14-3-3-like protein. Plant Physiol (1994) 1.12

In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. J Antimicrob Chemother (2005) 1.10

Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol (2000) 1.10

Human fibulin-1D: molecular cloning, expression and similarity with S1-5 protein, a new member of the fibulin gene family. Matrix Biol (1997) 1.09

Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis (1999) 1.08

In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med (2005) 1.07

Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob Agents Chemother (1993) 1.05

Molecular cloning, functional expression and chromosomal localization of an amiloride-sensitive Na(+) channel from human small intestine. FEBS Lett (2000) 1.04

Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis (2002) 1.03

Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer (2003) 1.01

Molecular cloning of a mammalian ABC transporter homologous to Drosophila white gene. Mamm Genome (1996) 1.01

Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Drugs Exp Clin Res (1992) 1.00

S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone (2003) 1.00

Hydatid cyst of the liver: comparison of CT and MRI. J Comput Assist Tomogr (1993) 0.99

Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc (2006) 0.98

A decade-long surveillance of nasopharyngeal colonisation with Streptococcus pneumoniae among children attending day-care centres in south-eastern France: 1999-2008. Eur J Clin Microbiol Infect Dis (2011) 0.97

Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med (1998) 0.97

Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial. AIDS Care (2010) 0.97

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clin Infect Dis (2008) 0.97

Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone (1996) 0.95

In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea. Cancer Chemother Pharmacol (1990) 0.93

Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients. Clin Exp Immunol (1999) 0.93

[NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV]. Presse Med (2003) 0.92

In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells. J Biol Regul Homeost Agents (1997) 0.91

[Infantile Mediterranean kala-azar in the southeast of France. Current considerations]. Ann Pediatr (Paris) (1987) 0.91

Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients. AIDS (2001) 0.91

Changing trends in pregnancy outcome among HIV-infected women between 1985 and 1997 in two southern French university hospitals. Eur J Obstet Gynecol Reprod Biol (2002) 0.91

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV Med (2010) 0.90

Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol (2000) 0.90

Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents (2013) 0.88

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study. HIV Med (2003) 0.87

Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis. J Pathol (1996) 0.87

In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother (1995) 0.87

Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study. Eur J Clin Microbiol Infect Dis (2012) 0.87

[Hospital medical students: a population at risk for accidental exposure to blood]. Presse Med (1998) 0.86

Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. Mamm Genome (1997) 0.86

The MHC class-II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer (1994) 0.86

Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin. Br J Cancer (1992) 0.85

New perspectives offered by a French study of antibiotic resistance in day-care centers. Chemotherapy (1998) 0.85

[Motives for the prescription of antibiotics in the emergency department of the University Hospital Center in Nice. A prospective study]. Presse Med (2002) 0.85

Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy. AIDS (2001) 0.85

HIV prenatal screening in south-eastern France: differences in seroprevalence and screening policies by pregnancy outcome. AIDS Care (1994) 0.84

[Enterobacterial native valve endocarditis in the intensive care unit: report of two cases]. Rev Med Interne (2000) 0.83

Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy. Ann Intern Med (2002) 0.83

Factors related to delayed diagnosis of HIV infection in southeastern France. EVALVIH group. Int J STD AIDS (2000) 0.82

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. HIV Med (2014) 0.82

Isolation and chromosomal location of mE4, a novel murine gene of the immunoglobulin superfamily. Mamm Genome (1996) 0.82

Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2. Nephron Clin Pract (2012) 0.82

Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strains. Drugs (1995) 0.81

Late acquisition of hyporesponsiveness to lipopolysaccharide by Mycobacterium avium-infected human macrophages in producing tumor necrosis factor-alpha but not interleukin-1 beta and -6. J Infect Dis (1996) 0.81

Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count? AIDS (1998) 0.81

Induction of graft versus host disease in SCID mice by MRL/lpr cell transfer. Clin Immunol Immunopathol (1994) 0.81

Continuous noninvasive measurement of aortic blood flow in critically ill patients with a new esophageal echo-Doppler system. J Crit Care (1998) 0.81

[Acute ischemic syndrome and apparently spontaneous spasms of the lower leg arteries]. Coeur Med Interne (1981) 0.81

Mycobacterium avium infection in BALB/c and SCID mice. J Med Microbiol (1999) 0.80

Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors. Eur J Clin Microbiol Infect Dis (1994) 0.80

Characterization of human pancreatic adenocarcinoma cell line with high metastatic potential in SCID mice. Invasion Metastasis (1995) 0.80

In vitro development of resistance of Streptococcus pneumoniae to beta-lactam antibiotics. Microb Drug Resist (1995) 0.80

Needlestick injuries among French medical students. JAMA (1999) 0.80

Antimicrobial stewardship program and quality of antibiotic prescriptions. Med Mal Infect (2011) 0.80

Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. Eur J Drug Metab Pharmacokinet (2000) 0.79

Assignment of transcription factor NFAT5 to human chromosome 16q22.1, murine chromosome 8D and porcine chromosome 6p1.4 and comparison of the polyglutamine domains. Cytogenet Cell Genet (2000) 0.79

[Persistent diarrhea in HIV infected patients: role of Enterocytozoon bieneusi]. Presse Med (1995) 0.79

A third human CBL gene is on chromosome 19. Int J Oncol (1998) 0.79

[Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers]. Pathol Biol (Paris) (1991) 0.79

Bloodless hepatic resection with automatic bipolar radiofrequency generator and multielectrode device. Minim Invasive Ther Allied Technol (2007) 0.78

Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige mice. Antimicrob Agents Chemother (1998) 0.78

Augmented passive transfer of contact sensitivity in severe combined immunodeficiency mice and its dependence of V beta 8+ cells in the picryl system. Int Arch Allergy Immunol (1993) 0.78

[HIV exposure accidents in children. Experience at the emergency admission services of the CHU of Nice]. Arch Pediatr (2002) 0.78

[Community-acquired and nosocomial septicemias in patients with human immunodeficiency virus infection]. Presse Med (1996) 0.78

Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. AIDS Res Hum Retroviruses (1996) 0.78

Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study). AIDS Care (2013) 0.78

Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity. Scand J Gastroenterol (2000) 0.77

Does fluconazole prevent cryptococcal meningitis in human immunodeficiency virus-infected patients? J Infect Dis (1992) 0.77

[Central apnea with consciousness impairment due to Listeria rhombencephalitis sequelae]. Rev Neurol (Paris) (1999) 0.77

Assignment of IL12RB2 to human chromosome 1p31.3-->p31.2 between D1S230 and D1S198. Cytogenet Cell Genet (1997) 0.77

AZT--does it prevent occurrence of salmonelloses in AIDS patients? J Intern Med (1991) 0.77